SCHEMBL5496245

SCHEMBL5496245

CCOc1ccc(/C=C/c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 1.00
RAB9A P51151 2/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
MTOR P42345 2/20 0.66
THPO P40225 1/20 0.66
HIF1A Q16665 1/20 0.66
KDM4E B2RXH2 2/20 0.64
ALDH1A1 P00352 2/20 0.64
GMNN O75496 1/20 0.64
LMNA P02545 1/20 0.64
BLM P54132 1/20 0.64
PMP22 Q01453 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
MAPT P10636 2/20 0.63
KMT2A Q03164 2/20 0.63
NPC1 O15118 2/20 0.63
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
ESR1 P03372 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL436231 1.00 RELA (1.00) RELARAB9ACYP1A2CYP3A4MTOR
SCHEMBL5572855 0.94 RELA (0.89) RELARAB9ACYP1A2CYP3A4MTOR
SCHEMBL2622564 0.92 RELA (0.85) RELARAB9ACYP1A2CYP3A4MTOR
SCHEMBL10623834 0.91 RELA (0.83) RELARAB9ACYP1A2CYP3A4THPO
SCHEMBL10623831 0.91 RELA (0.83) RELARAB9ACYP1A2CYP3A4THPO
Diphenylamine SCHEMBL10866114 0.89 RELA (0.80) RELARAB9ACYP1A2CYP3A4MTOR
SCHEMBL10866111 0.87 RELA (0.77) RELARAB9ACYP1A2CYP3A4MTOR
SCHEMBL11033784 0.87 RELA (0.77) RELARAB9ACYP1A2CYP3A4MTOR
SCHEMBL13267808 0.85 RELA (0.74) RELARAB9AKDM4EALDH1A1LMNA
SCHEMBL16604897 0.84 RELA (0.72) RELARAB9ACYP1A2CYP3A4MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980954-B2 Substituted cis- and trans-stilbenes as therapeutic agents STC.UNM (US) 2015-03-17 US claimed
US-9925153-B2 Therapeutic agents for skin diseases and conditions STC.UNM (US) 2018-03-27 US disclosed
US-9925153-B2 Therapeutic agents for skin diseases and conditions STC.UNM (US) 2018-03-27 US disclosed
US-9925153-B2 Therapeutic agents for skin diseases and conditions STC.UNM (US) 2018-03-27 US disclosed
US-20160287531-A1 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS STC.UNM 2016-10-06 US disclosed
US-20160287531-A1 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS STC.UNM 2016-10-06 US disclosed
US-20160287531-A1 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS STC.UNM 2016-10-06 US disclosed
WO-2015085143-A2 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS STC.UNM (US) 2015-06-11 WO disclosed
WO-2015085143-A2 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS STC.UNM (US) 2015-06-11 WO disclosed
US-8980954-B2 Substituted cis- and trans-stilbenes as therapeutic agents STC.UNM (US) 2015-03-17 US disclosed
US-20130178536-A1 SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS STC.UNM (US) 2013-07-11 US disclosed
US-20130178536-A1 SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS STC.UNM (US) 2013-07-11 US disclosed
US-20130178536-A1 SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS STC.UNM (US) 2013-07-11 US disclosed
US-20070249647-A1 Substituted CIS- and trans-stilbenes as therapeutic agents REGENTS OF THE UNIVERSITY OF NEW MEXICO 2007-10-25 US disclosed
US-20070249647-A1 Substituted CIS- and trans-stilbenes as therapeutic agents REGENTS OF THE UNIVERSITY OF NEW MEXICO 2007-10-25 US disclosed
US-20070249647-A1 Substituted CIS- and trans-stilbenes as therapeutic agents REGENTS OF THE UNIVERSITY OF NEW MEXICO 2007-10-25 US disclosed
EP-1268699-A4 ACRYLIC ADHESIVE COMPOSITIONS FOR POLARIZING FILM AND THE POLARIZER FILM USING THE SAME LG CHEMICAL LTD (KR) 2005-07-06 EP disclosed
EP-1268699-A1 ACRYLIC ADHESIVE COMPOSITIONS FOR POLARIZING FILM AND THE POLARIZER FILM USING THE SAME LG Chem Ltd. (KR) 2003-01-02 EP disclosed
WO-2002050209-A1 ACRYLIC ADHESIVE COMPOSITIONS FOR POLARIZING FILM AND THE POLARIZER FILM USING THE SAME LG CHEM, LTD. (KR) 2002-06-27 WO disclosed
US-20020015906-A1 Polymer for photoresist, method of production thereof and photoresist composition containing polymer SAMSUNG ELECTRONICS CO., LTD. (KR) 2002-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160287531-A1 THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS CUTA, TSLP, ELANE RELA 29/4885RAB9A 3557/4885CYP1A2 1332/4885
US-20070249647-A1 Substituted CIS- and trans-stilbenes as therapeutic agents TGFB1, VHL, TMSB10 RELA 12/4885RAB9A 3613/4885CYP1A2 1159/4885
US-20130178536-A1 SUBSTITUTED CIS- AND TRANS-STILBENES AS THERAPEUTIC AGENTS PSEN1, TERT, PSEN2 RELA 10/4885RAB9A 4212/4885CYP1A2 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.